SPA
MRNA icon

Sherbrooke Park Advisers’s Moderna MRNA Stock Holding History

Sherbrooke Park Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,531
Closed -$504K – 421
2025
Q3 		$504K Buy
+19,531
New +$545K 0.23% 167
2025
Q1 		– Sell
-5,710
Closed -$237K – 815
2024
Q4 		$237K Buy
+5,710
New +$273K 0.08% 511

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sherbrooke Park Advisers's MRNA Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Moderna (MRNA) in Q4 2025, closing a stake of 19,531 shares — an estimated $504K sold.

Sherbrooke Park Advisers first reported a position in MRNA in Q4 2024 and held it in 2 quarters. The position peaked at $504K in Q3 2025. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 19,531 Moderna shares in Q4 2025, an estimated $504K.
  • Sherbrooke Park Advisers first reported a position in Moderna in Q4 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Moderna position peaked at $504K in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.